Assertio Therapeutics Stock News

U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday. The Dow traded down 0.59% to 32,868.65 while the NASDAQ fell 0.12% to 12,366.62. The S&P 500 als

Gainers Windtree Therapeutics, Inc. (NASDAQ: WINT) shares surged 60.5% to $0.7238 after the company announced it has entered into a global licensing agreement for the development and commercializatio

U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.16% to 33,010.58 while the NASDAQ rose 0.27%

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) shares rose 34.5% t

LAKE FOREST, Ill., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products

LAKE FOREST, Ill., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products

Here is how Axonics Modulation Technologies (AXNX) and Assertio (ASRT) have performed compared to their sector so far this year.

Assertio Holdings has expanding sales and strong margins. ASRT is making moves to save money on debt servicing with strong cash on hand.

Jazz Pharmaceuticals (JAZZ) initiates a two-part pivotal late-stage study evaluating its epilepsy drug, Epidiolex, in children and adolescents suffering from epilepsy with Myoclonic-Atonic Seizures (E

Assertio Holdings, Inc. (NASDAQ:ASRT ) Q2 2022 Earnings Conference Call August 8, 2022 11:30 AM ET Company Participants Matthew Kreps - Darrow Associates, IR Daniel Peisert - President and CEO Paul Sc

Assertio (ASRT) delivered earnings and revenue surprises of 100% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Assertio (ASRT) delivered earnings and revenue surprises of 100% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Here is how Assertio (ASRT) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.

Here is how Assertio (ASRT) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.

ASRT vs. CTLT: Which Stock Is the Better Value Option?